FDA Inspection 1077023 - Lonza Guangzhou Pharmaceutical Ltd. - December 14, 2018
FDA Inspection 1077023 for Lonza Guangzhou Pharmaceutical Ltd. on December 14, 2018. Classification: No Action Indicated (NAI).
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
FDA Inspection 1077023 for Lonza Guangzhou Pharmaceutical Ltd. on December 14, 2018. Classification: No Action Indicated (NAI).
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Inspection Date
December 14, 2018
Product Type
Drugs
ID: 080a49f9-1715-46b2-9ed7-5d25bf4dba0b
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox